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Background: This general practice-based case-control study tested the association between cerebrovascular risk factors (CVRFs)
and the development of later-life depression by focusing on the impact of exposure duration to CVRFs and the modifying influence
of age at depression onset.
Methods: Cases were 286 patients aged ≥50 years with a first diagnosis of depression at age ≥50 years. Nondepressed controls
(N=832) were individually matched for age, gender and practice. CVRF diagnoses (hypertension, diabetes mellitus, cardiovascular
conditions) prior to depression were determined. Analyses controlled for education, somatic and nondepressive psychiatric disease.
Results: No CVRF variable examined was significantly associated with subsequent depression in the total sample. An unexpected
impact of age at onset of depression was observed: the odds ratio associated with having any CVRF was smaller for patients with
age at onset ≥70 years than for patients with onset between ages 50–59 years (p=.002) and 60–69 years (p=.067). Subsequent
analyses excluding patients with onset at age ≥70 years revealed that CVRF variables, including long-term exposure to CVRFs,
significantly increased the odds of subsequent depression with onset between ages 50 and 69 years.
Limitations: Reliance on GPs' records of morbidity may have resulted in bias towards underestimation in patients with depression
onset at age ≥70 years.
Conclusions: Our findings suggest that CVRFs play a relevant role in the development of depression with onset between ages 50
and 69 years, but no evidence was found that they contribute to the occurrence of depression with onset at age ≥70 years.
Replication is warranted to exclude the possibility of bias.
© 2006 Elsevier B.V. All rights reserved.Keywords: Depression; Cerebrovascular risk factors; Age at onset of depression; General practice⁎ Corresponding author. NIVEL (Netherlands Institute for Health
Services Research), PO Box 1568, 3500 BN Utrecht, The Netherlands.
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doi:10.1016/j.jad.2006.08.0111. Introduction
The vascular depression hypothesis proposes that ce-
rebrovascular disease is an important aetiological factor
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Krishnan et al., 1997). An implication of this hypothesis
is the existence of an association between cerebrovascu-
lar risk factors (CVRFs), such as hypertension, diabetes
mellitus and cardiac disease, and depression in later life.
More specifically, Lyness et al. (1998, 1999) have sug-
gested that the increase in prevalence of CVRFs with age
contributes over time to the development of small-vessel
brain disease, which, in turn, disrupts neurobiological
functioning resulting in depression.
Most studies testing the link between CVRFs and
later-life depression have been cross-sectional and used
predominantly samples of psychiatric patients. These
reports have yielded mixed results (Azar et al., 2005;
Baldwin and Tomenson, 1995; Greenwald et al., 1996;
Hickie et al., 2001; Lyness et al., 1998, 1999; Krishnan
et al., 1995; Mast et al., 2004a; Stewart et al., 2001;
Taylor et al., 2004). A major limitation of these studies
is their transversal design. Given that depression may
also contribute to the development of CVRFs (e.g.,
Meyer et al., 2004; Van den Akker et al., 2004; Williams
et al., 2002; Wulsin and Singal, 2003), it is essential to
perform longitudinal studies that specifically address the
hypothesized causal pathway of CVRFs leading to the
development of depression.
To the best of our knowledge, only two prospective
studies have directly examined this association and their
results are equivocal. In older primary care patients,
Lyness et al. (2000) detected no relationship between
baseline severity of CVRFs and depression symptoms
and diagnoses at 1-year follow-up after controlling for
overall medical burden. Conversely, Mast et al. (2004b)
investigated geriatric rehabilitation patients and found
an association between a higher number of CVRFs at
baseline and the manifestation of depressive symptoms
at 6 and 18 months follow-up, also after adjusting for
baseline depression scores, limitations in activities of
daily living and general medical comorbidity. It is un-
clear what explains this inconsistency in findings, but
differences in patient characteristics may play a role, as
well as limitations within the studies. The study by
Lyness et al. included patients who were depressed at
baseline, rather than focusing exclusively on newly
onset depression. Mast et al. examined a specific clinical
sample, which was potentially subject to referral bias
and focused on a restricted set of three CVRFs (i.e.,
hypertension, diabetes and atrial fibrillation).
Both longitudinal studies did not examine the impact
of the duration of exposure to CVRFs as well as the
potential moderating influence of age at onset of de-
pression. Since the theoretical model by Lyness et al.
(1998, 1999) postulates that CVRFs produce depressionthrough the development of small-vessel brain disease
over time, exposure duration to CVRFs is an essential
factor to be taken into consideration. In addition, age at
depression onset may modify the relationship between
CVRFs and the subsequent development of depression.
Given that the prevalence of, and consequently exposure
duration to, CVRFs generally will increase with age,
one would expect the association between CVRFs and
subsequent depression to be stronger in patients with an
older age at depression onset compared with patients
with a younger age at onset.
The aim of the present case-control study was to
further test the association between CVRFs and the
subsequent development of depression in older general
practice patients. Besides investigating the influences of
having any CVRF, specific CVRFs and the number of
CVRFs, we examined the effect of exposure duration to
CVRFs on the development of depression in later life. In
addition, the potential modifying influence of age at
depression onset on the relationship between CVRFs
and subsequent later-life depression was investigated.
2. Methods
2.1. Study setting and data
This study was a sub-study of the second Dutch Na-
tional Survey of General Practice (2001) (Westert et al.,
2005) and utilized morbidity data recorded by general
practitioners (GPs). In the Netherlands, GPs act as a
gatekeeper to health care facilities. After referral, spe-
cialists report back results, by which GPs have compre-
hensive information about the health status of a patient.
The majority of Dutch GPs keep electronic medical
records of their patients as part of daily medical practice.
An important element of these records, initially formu-
lated byWeed (1969), are the so-called “problem lists.”A
problem list contains diagnoses of all relevant past and
current health problems of a patient, with a health
problem defined as “anything that has required, does or
may require health care management and has affected or
could significantly affect a person's physical or emotion-
al well-being” (Metsemakers et al., 1992). The dates of
establishing the diagnoses are also recorded. Health
problems are coded by the GPs according to the Inter-
national Classification of Primary Care (ICPC) (Lamberts
and Woods, 1987) based on the criteria of the Inter-
national Classification of Health Problems in Primary
Care (ICHPPC-2-Defined) (WONCA, 1983).
For the present study, eight practices, comprising 14
GPs, were selected on the basis of their fulfillment of
quality criteria relating to the accuracy of dates of
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completeness of the registration. These practices took
part in a procedure to increase the completeness of the
problem lists concerning diagnoses of depressive dis-
order (ICPC code P76) and heart failure (code K77).
This procedure involved running a computer search
program that, by searching the entire electronic medical
record system for markers (e.g., relevant ICPC codes,
certain text strings, specific medication), traced potential
cases of depression and heart failure. Subsequently, for
each identified possible diagnosis of depression or heart
failure, the GP made a decision to add the diagnosis to
the problem list.
2.2. Study population
The population registered at the eight practices con-
sisted of 28,307 persons in 2001 and was representative
of the Dutch population in terms of age, gender and type
of health insurance. The practice population formed the
source population.
Cases were defined as patients aged 50 years or
older in 2001 who were diagnosed with depressive
disorder (ICPC code P76) or depressive feelings (code
P03) for the first time at age 50 years or older
according to their problem list. The ICHPPC-2-
Defined criteria for depressive disorder correspond
largely to those of the DSM-IV for major depression
(Van den Akker et al., 2004). The P03 code is used for
patients with depressive symptomatology who do not
fulfill criteria for depressive disorder. Cases diagnosed
with stroke or transient ischaemic attack (TIA) and/or
dementia before the date of depression diagnosis were
excluded (N=20) to minimize the influence of
clinically overt cerebrovascular disease and dementia
on the relationship between CVRFs and subsequent
depression, leaving 286 cases.
Controls comprised those patients who had never
received a diagnosis of depression or depressive feel-
ings, but who had at least one other diagnosis on their
problem list. This latter requirement was imposed to
minimize selectivity due to the degree of attention a GP
pays to a patient. For each depressed case, three control
patients matched on age (using 5 year age bands), gen-
der and practice were randomly selected. Each matched
control was assigned a virtual “exit date” marking the
end of the observation period, which was identical to the
date of depression diagnosis of the case with whom the
control was matched. Controls with a diagnosis of stroke
or TIA and/or dementia before the exit date were ex-
cluded. A small number of cases were matched to less
than three control patients because the number of eli-gible controls was not sufficient, resulting in 832 control
patients.
2.3. Cerebrovascular risk factors (CVRFs)
The current study investigated the following well-
established CVRFs (Goldstein et al., 2006; Wolf et al.,
1991): hypertension (ICPC codes K86 or K87),
diabetes mellitus (code T90) and several cardiovascular
conditions, including atrial fibrillation (code K78),
chronic ischemic heart disease (code K76), angina
pectoris (code K74), myocardial infarction (code K75),
heart failure (code K77), and intermittent claudication
(code K92). Diagnoses of hypertension, diabetes
mellitus, and chronic ischemic heart disease made by
GPs have been shown to agree well with the diagnostic
criteria of the ICHPPC-2-Defined, with a highest false
positive rate of 4% being observed in diabetes mellitus
(Schellevis et al., 1993).
For each case (control), the presence of each CVRF
diagnosis prior to the date of depression diagnosis (as-
signed exit date) was determined, as well as the time
periods between the date of each CVRF diagnosis and
depression diagnosis date (assigned exit date). The in-
fluence of the following CVRF variables on the devel-
opment of subsequent depression was examined: a basic
variable “any CVRF” (i.e., any CVRF diagnosis), indi-
vidual CVRFs (i.e., three CVRF diagnosis categories:
hypertension, diabetes mellitus and cardiovascular con-
ditions), the number of CVRFs (i.e., the number of
diagnoses belonging to a different CVRF category; pos-
sible range=0–3) and the duration of exposure to
CVRFs. Regarding this last variable, if a case or control
had CVRF diagnoses in more than one category, the time
periods between each CVRF diagnosis within the cate-
gory and depression diagnosis were summed (e.g., hy-
pertension and diabetes mellitus diagnosed, respectively,
7.7 and 3.0 years before depression diagnosis resulted in
a total exposure duration of 10.7 years). Subsequently,
this variable was categorized into 0, N0–10, N10–20,
and N20 years of exposure. Of note, atrial fibrillation was
included in the cardiovascular category and not consid-
ered separately because the number of cases with this
condition was too small for meaningful analysis.
2.4. Covariates
We took into account other factors that might in-
fluence the associations between the CVRF variables and
subsequent depression, including attained educational
level, other psychiatric disorder and the number of chron-
ic somatic disorders present prior to the development of
Table 1






Mean age (in 2001),
years (S.D.) range
68.1 (10.1) 51–92 67.8 (10.0) 51–95
Female gender, N (%) 191 (67.0) 557 (67.0)
Educational level, N (%)
High 27 (9.5) 71 (8.5)
Middle 106 (37.2) 337 (40.6)
Low 105 (36.8) 269 (32.4)








0 75 (26.3) 229 (27.6)
1 67 (23.5) 223 (26.8)
2 49 (17.2) 148 (17.8)
≥3 94 (33.0) 231 (27.8)
Any CVRF prior to
depression, N (%)
80 (28.1) 205 (24.7)
Individual CVRF prior to
depression, N (%)
Hypertension 53 (18.6) 131 (15.8)
Diabetes 19 (6.7) 43 (5.2)
Any cardiovascular
condition




1 61 (21.4) 158 (19.0)





N0–10 55 (19.3) 144 (17.3)
N10–20 9 (3.2) 30 (3.6)
N20 16 (5.6) 31 (3.7)
CVRF: cerebrovascular risk factor.
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categorized into low (none, elementary school), middle
(high school) and high (college or university). Also, a
separate category of missing data was created because
education data were missing for a substantial number of
cases (16.4%) and controls (18.5%). The presence of
psychiatric disease was defined as having at least one
psychiatric diagnosis other than depression or depressive
feelings diagnosed before depression diagnosis date (for
cases) or “exit date” (for controls), respectively. The
following psychiatric diagnoses were taken into account:
anxiety disorders, schizophrenia and other psychotic dis-
orders, and a rest category of other mental disorders. The
number of chronic somatic conditions prior to depression
was established in a similar fashion, while considering a
comprehensive range of conditions relating to various
body systems (Nuyen et al., in press). This variable was
categorized into four categories, i.e., 0, 1, 2 and ≥3
conditions.
2.5. Statistical analysis
Separate conditional logistic regression analyses were
performed using SPSS version 11.5 for Windows (http://
www2.chass.ncsu.edu/garson/PA765/logit.htm) to exam-
ine the association between each of the CVRF variables
and the subsequent development of depression in the total
sample. The potential confounding effects of attained
educational level, presence of other psychiatric disease
and the number of chronic somatic conditions prior to
depression were controlled for in multivariate models.
Next, to examine the potential modifying influence of
age at onset of depression, three “age at depression onset”
groups were formed consisting, respectively, of cases
with depression onset between ages 50 and 59 years
(N=149) and their matched controls (N=439), of cases
with onset between ages 60 and 69 years (N=70) and
their matched controls (N=202), and of cases with onset
at age 70 years or older (N=67) and their matched
controls (N=191). This categorization was based on the
most commonly employed cut-off points, i.e., 50 and
60 years of age, to define late-onset depression (Van den
Berg et al., 2001). To investigate whether there existed a
different relationship between having any CVRF and
subsequent depression for the three age at depression
onset groups, an interaction term of any CVRF and age at
depression onset group was added to the multivariate
model. Interaction was tested by comparing the log like-
lihood of this model with that of the model without the
interaction term (i.e., likelihood ratio test). In case of a
significant interaction effect, the odds ratio of developing
depression for patients with any CVRF in each of thethree age at depression onset groups were assessed using
multivariate conditional logistic regression analysis.
Finally, as a sensitivity analysis, all analyses were
repeated while excluding cases that were diagnosed with
depressive feelings (N=16) and their matched controls
(N=48) to evaluate the effect of possible misclassifica-
tion of depression. Also, the modifying influence of age
at depression onset was examined using a more detailed
classification of age at onset groups (i.e., onset between
ages 50–54, 55–59, 60–64, 65–69, 70–74 years and
onset at ≥75 years) to evaluate the influence of defi-
nition of age at onset categorization.
Statistical significance was accepted at the 5% level.
Table 3
Association between having any cerebrovascular risk factor (CVRF)
and subsequent depression in three “age at depression onset” groups
using multivariate conditional logistic regression analysis
OR (95% CI) p*
Any CVRF with age at depression onset
50–59 years
1.88 (1.12–3.14) .016
Any CVRF with age at depression onset
60–69 years
1.23 (0.64–2.35) .542
Any CVRF with age at depression onset
≥70 years
0.53 (0.28–0.99) .045
Analysis controlled for educational level, presence of other psychiatric
disease and number of somatic diseases prior to depression.
The reference category is patients without CVRFs.
OR: odds ratio, CI: confidence interval, *Wald chi-square test.
Table 4
Demographic and clinical characteristics of depressed cases with







Mean age (in 2001) years (S.D.)
Range
64.2 (7.6) 51–87 64.2 (7.7) 51–90
Female gender, N (%) 137 (62.8) 404 (63.0)
Educational level, N (%)
High 23 (10.6) 66 (10.3)
Middle 91 (41.7) 282 (44.0)
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Table 1 illustrates the demographic and clinical char-
acteristics of the depressed patients (N=285) and their
matched controls (N=831).
Table 2 shows the results of the conditional logistic
regression analyses examining the association between
each of the CVRF variables and the subsequent devel-
opment of depression. None of the CVRF variables was
significantly linked to subsequent depression. Addition-
ally controlling for educational level, other psychiatric
disease and number of chronic somatic conditions only
minimally affected the odds ratios.
Next, the potential modifying influence of age at
depression onset on the relationship between having any
CVRF and subsequent depression was examined. Note-
worthy, the proportion of cases and controls with any
CVRF differed across the age at depression onset
groups, suggesting a modifying role of age at depression
onset. Specifically, in the groups with onset between
ages 50 and 59 years (mean age 61.3, S.D. 6.9, 58.9%
females) and 60 and 69 years (mean age 70.5, S.D. 5.0;
71.7% females) having any CVRF was more common
among cases than controls (22.3% vs. 13.7% and 32.9%
vs. 27.7%, respectively). In contrast, in the group with
onset at age 70 years or older (mean age 80.3, S.D. 5.9;
80.5% females), a lower proportion of cases than con-
trols had any CVRF (35.8% vs. 46.8%). Indeed, aTable 2
Association between cerebrovascular risk factor (CVRF) variables and
subsequent depression using separate conditional logistic regression
analyses
Bivariate Multivariate
OR (95% CI) p* OR (95% CI) p*
Any CVRF 1.18 (0.85–1.64) .33 1.18 (0.80–1.59) .49
Individual CVRF
Hypertension 1.23 (0.84–1.80) .30 1.18 (0.80–1.75) .41
Diabetes 1.28 (0.73–2.26) .39 1.20 (0.67–2.13) .55
Any cardiovascular
condition
0.96 (0.60–1.54) .86 0.85 (0.52–1.40) .53




N0–10 1.15 (0.78–1.69) .48 1.15 (0.78–1.71) .48
N10–20 0.91 (0.42–1.96) .80 0.83 (0.38–1.82) .65
N20 1.56 (0.82–2.97) .17 1.32 (0.67–2.60) .42
Bivariate analysis controlled for the matching variables gender, age
and practice. Multivariate analysis additionally controlled for
educational level, presence of other psychiatric disease and number
of somatic diseases prior to depression.
The reference category for exposure duration to CVRFs is 0 years.
OR: odds ratio, CI: confidence interval, *Wald chi-square test.
Low 66 (30.3) 176 (27.5)
Missing 38 (17.4) 117 (18.3)
Other psychiatric disease prior
to depression, N (%)
23 (10.6) 23 (3.6)
Number of somatic diseases
prior to depression, N (%)
0 67 (30.7) 198 (30.9)
1 52 (23.9) 187 (29.2)
2 34 (15.6) 116 (18.1)
≥3 65 (29.8) 140 (21.8)
Any CVRF prior to depression,
N (%)
56 (25.7) 116 (18.1)
Individual CVRF prior to
depression, N (%)
Hypertension 36 (16.5) 74 (11.5)
Diabetes 17 (7.8) 24 (3.7)
Any cardiovascular condition 15 (6.9) 37 (5.8)
Number of individual CVRFs
prior to depression, N (%)
1 44 (20.2) 97 (15.1)
2 12 (5.5) 19 (3.0)
Exposure duration to CVRFs
prior to depression, sum of
years, N (%)
N0–10 37 (17.0) 84 (13.1)
N10–20 8 (3.7) 19 (3.0)
N20 11 (5.0) 13 (2.0)
CVRF, cerebrovascular risk factor.
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depression onset group (likelihood ratio test: p=.010)
confirmed that the influence of having any CVRF dif-
fered by age at depression onset group. A subsequent
multivariate logistic regression (Table 3) showed that,
relative to patients without CVRFs, having any CVRF
significantly increased the odds of developing depres-
sion in the group with onset between ages 50 and
59 years. In the group with onset between ages 60 and
69 years, having any CVRF also increased the like-
lihood of subsequent depression, although this relation-
ship was not significant. In contrast, in the group with
onset at age 70 years or older, having any CVRF was
associated with a significantly decreased odds of devel-
oping depression compared to patients without CVRFs.
Furthermore, the odds ratio associated with having any
CVRF in this oldest age at depression onset group was
significantly smaller than that observed in the group
with depression onset between ages 50 and 59 years
(p=.002) and tended to be significantly smaller than the
odds ratio for the group with onset between ages 60 and
69 years (p=.067). The odds ratios associated with
having any CVRF did not differ significantly between
the two younger age at depression onset groups (p=.31).
Using a more detailed classification of age at depression
onset yielded essentially similar results.Table 5
Association between cerebrovascular risk factor (CVRF) variables and
subsequent depression with onset between ages 50 and 69 using
separate conditional logistic regression analyses
Bivariate Multivariate
OR (95% CI) p⁎ OR (95% CI) p⁎
Any CVRF 1.61 (1.08–2.39) .019 1.56 (1.03–2.35) .034
Individual CVRF
Hypertension 1.59 (0.99–2.55) .057 1.57 (0.96–2.55) .071




1.16 (0.62–2.19) .64 1.02 (0.53–1.98) .95
Number of CVRFs
(0–2)




N0–10 1.45 (0.90–2.32) .12 1.42 (0.88–2.31) .15
N10–20 1.36 (0.57–3.26) .49 1.30 (0.53–3.17) .57
N20 2.80 (1.20–6.54) .018 2.64 (1.10–6.35) .031
Bivariate analysis controlled for the matching variables gender, age
and practice. Multivariate analysis additionally controlled for
educational level, presence of other psychiatric disease and number
of somatic diseases prior to depression.
The reference category for exposure duration to CVRFs is 0 years.
CVRF: cerebrovascular risk factor; OR: odds ratio; CI: confidence
interval; *Wald chi-square test.Given these results, we repeated our analyses con-
cerning the CVRF variables under study while exclud-
ing the cases with an age at depression onset of 70 years
or older and their matched controls. The demographic
and clinical characteristics of the sub-sample are shown
in Table 4, and Table 5 presents the regression results.
Having any CVRF significantly increased the odds of
developing depression with onset between ages 50 and
69 years. Regarding individual CVRFs, the influence of
having hypertension tended to be significant in both the
bivariate and the multivariate model. Having diabetes
significantly increased the likelihood of onset of depres-
sion between ages 50 and 69 years, while having any
cardiovascular condition did not. Furthermore, a higher
number of CVRFs was found to exert a significant effect.
Additionally, patients who were exposed to CVRFs for
more than 20 years were significantly more likely to have
subsequent depression with onset between ages 50 and
69 years than patients who had no exposure to CVRFs.
Finally, repeating all analyses after excluding cases with
depressive feelings and their matched controls yielded
basically similar results.
4. Discussion
In this general practice-based case-control study, none
of the CVRF variables examined, including exposure
duration to CVRFs, was significantly associated with the
subsequent development of depression in later life. In
addition, the results refuted our hypothesis that the
relationship between having any CVRF and subsequent
depression would be stronger in patients with an older
age at depression onset compared with patients with a
younger age at onset. That is, the odds ratio associated
with having any CVRF was significantly smaller in the
group with age at depression onset at age 70 years or
older than in the group with onset of depression between
ages 50 and 59 years and tended to be significantly
smaller than the odds ratio observed in patients with onset
of depression between ages 60 and 69 years. Subsequent
analyses excluding the oldest age at depression onset
group showed significant associations between CVRF
variables, including long-term exposure duration to
CVRFs, and subsequent depression with onset between
ages 50 and 69 years. An interpretation of these findings
is that CVRFs play a relevant role in the development of
depression with onset between ages 50 and 69 years, but
that no evidence was found that CVRFs contribute to the
occurrence of depression with onset at age 70 years or
later.
However, strengths and limitations of the reliance on
morbidity data recorded by GPs must be considered
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the data allowed us to examine the influence of exposure
to CVRFs over a lengthy period of time, rather than
merely investigating the impact of presence or severity of
CVRFs at a given time point. Another strength was that a
largely unselected group was studied because almost all
non-institutionalized Dutch citizens are registered with a
GP. Therefore, potential referral bias was minimal. Fur-
thermore, a possible influence of recall bias concerning
onset data was minimized because these were ascertained
on the basis of dates of diagnosis recorded by GPs instead
of based on patient recall. Relying on GPs' records of
morbidity has also limitations.
First, it is likely that the problem lists were not
entirely complete regarding diagnoses of depression and
CVRFs despite the implemented procedure to increase
their completeness. Theoretically, this could have re-
sulted in spurious significant results when the degree of
completeness of the recorded CVRF diagnoses was
substantially greater among cases than controls. How-
ever, we minimized this potential bias towards overes-
timation by including only controls who had at least one
record of a health condition on their problem list. Sec-
ond, only a limited range of CVRFs could be studied
because the available data did not allow us to examine
the influence of other risk factors (e.g., smoking, dys-
lipidemia), though not taking into consideration other
CVRFs would most likely have attenuated a true rela-
tionship between CVRFs and depression rather than
producing a spurious one. Third, examining diagnosis of
depression made by GPs and not diagnosis based on a
standardized assessment procedure may have led to a
substantial misclassification of subjects who actually
developed depression as not having had this disorder
(i.e., underdiagnosis) and visa versa (i.e., overdiagnosis).
At least, the rather low incidence of “depressive feelings”
does suggest considerable underdiagnosis of subthresh-
old depression. If there is a true relationship between
CVRFs and depression, misclassification of depression
and/or depressive feelings would have resulted in an
underestimation of the associations under study, though,
in case of differential misclassification, there is also the
possibility of overestimating effects. For instance, under-
diagnosis of depressionmay occur less frequently among
patients with CVRFs because GPs have raised awareness
of depression in these patients. However, we consider
this unlikely for two reasons. First, as our study con-
cerned older patients and only control patients were
includedwho had been diagnosedwith at least one health
problem, the majority of the patients not suffering from
CVRFs (i.e., 71%) had at least one somatic disease
before the date of depression diagnosis (cases) or as-signed “exit date” (controls). Given this high number
together with the fact that these health problems in
general concern conditions that require health care ma-
nagement and significantly affect a person's physical or
emotional well-being (Metsemakers et al., 1992), it is
likely that most patients without CVRFs were also sub-
ject to increased vigilance by GPs. Second, it remains to
be seen whether having CVRFs, or more broadly having
a chronic somatic illness, leads to increased detection of
depression by GPs. In fact, studies have suggested an
opposite effect; that is, they have found that somatically
ill patients who have comorbid major depression have a
higher risk of not being diagnosed as depressed by GPs
than those without a somatic illness (Sartorius et al.,
1996; Nuyen et al., 2005). A final limitation of our study
is that only patients who were alive at the time of data
collection were examined. There is growing evidence
that depression significantly increases the risk of death in
adults with diabetes (Zhang et al., 2005), cardiovascular
disease (Barth et al., 2004; Wulsin et al., 1999) or hy-
pertension (Simonsick et al., 1995). If so, differential
mortality would have resulted in the non-participation of
more cases than controls with CVRFs, which, in turn,
would have led to an underestimation of the associations
under study.
Having addressed potential sources of bias, we cannot
rule out the possibility that bias towards underestimation
explains the “failure” to find any of the CVRF variables
to be significantly associated with the development of
later-life depression in our total sample. That is, it is
possible that particularly in the oldest age at depression
onset group (onset ≥70 years) a significant bias towards
underestimation was present because (1) the rate of
overdiagnosis and especially underdiagnosis of depres-
sion by GPs may be higher in older age groups than
among younger age groups (Stek et al., 2004; Volkers
et al., 2004), and/or because (2) the mortality rate of
patients with CVRFs and comorbid depression may be
higher in patients with an older age at depression onset
relative to patients with a younger age at depression onset
(Philibert et al., 1997). Such pronounced conservative
bias in the oldest age at depression onset group could
have masked “true” relationships between CVRFs and
subsequent later-life depression in our total sample,
which only came into sight when this group was ex-
cluded from analysis. Further longitudinal research that
circumvents the potential biases addressed above is
needed to settle the role of CVRFs in the development of
depression with onset at age 70 years or older. Anyhow,
our findings may help explain why Lyness et al. (2000)
did not find significant associations between CVRF var-
iables at baseline and subsequent depression symptoms
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overall medical burden. They examined a sample of
primary care patients aged 60 years or older and also
conducted separate analyses using a subset of patients
with onset at age 60 years or later. However, no analyses
were performed excluding patients with depression onset
at age 70 years or older.
This is the first study that examined the association
between duration of CVRFs exposure over time and the
development of later-life depression. We found that
patients who were exposed to CVRFs for more than
20 years were significantly more likely to develop de-
pression with age at onset between 50 and 69 years than
patients without CVRFs. In the context of the proposed
model of Lyness et al. (1998, 1999), this suggests that a
long-term exposure to CVRFs is required before they
contribute via the development of small-vessel brain
disease to the occurrence of depression in later life. It
should be noted that our measure of exposure duration
to CVRFs weighted each individual CVRF (hyperten-
sion, diabetes, cardiovascular disease) equally and also
did not take into account treatment of CVRFs. Addi-
tionally, in case of exposure to more than one specific
CVRF, the exposure duration to each CVRF was simply
summed. It is possible that the association between
CVRFs and subsequent later-life depression varies with
(the exposure duration to an) individual CVRF and that,
consequently, each individual CVRF has to be given
a specific weight. Our findings concerning specific
CVRFs suggest that diabetes and hypertension may play
a more important role than cardiovascular conditions in
the development of depression in later life. Only a
limited number of previous longitudinal studies have
examined the association between a specific CVRF and
the development of depression and their results are
inconsistent (Eaton, 2002; Lyness et al., 2000; Patten,
2001; Polsky et al., 2005). Also, the influence of age at
depression onset was not considered in these studies.
Further prospective studies are needed to determine
whether long-term exposure to CVRFs exerts its effect
on the development of later-life depression regardless of
type of CVRF or that specific (combinations of) CVRFs
do matter.
In sum, although our findings were essentially neg-
ative using the total sample of older general practice
patients, results of subsequent analyses excluding the
patients with onset of depression at age 70 years or
older offered support for a longitudinal relationship
between CVRFs and subsequent depression in later
life. Replication is needed to exclude the possibility
that our findings were substantially influenced by
biases inherent to relying on morbidity data recordedby GPs. Ideally, such future research should take into
account several other variables that appear to moderate
the association of CVRFs with later-life depression,
including executive functioning (Mast et al., 2004c),
severe life stress preceding onset of depression (Holley
et al., 2006; Van den Berg et al., 2001) and physical
symptoms and limitations (Mast et al., 2005).
Ultimately, subgroups of patients could be identified
for whom the vascular depression concept is particu-
larly relevant, which, in turn, may guide prevention of
depression in later life through modification of
CVRFs.
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